{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:17:42Z","timestamp":1793215062583,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Scientific research Project Plan of Shanghai Municipal Health Commission","award":["No.202140346"],"award-info":[{"award-number":["No.202140346"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>cblC defect is the most common type of methylmalonic acidemia in China. Patients with late-onset form (&gt;1 year) are often misdiagnosed due to heterogeneous symptoms. This study aimed to describe clinical characteristics and evaluate long-term outcomes of Chinese patients with late-onset cblC defect.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 85 patients with late-onset cblC defect were enrolled. Clinical data, including manifestations, metabolites, molecular diagnosis, treatment and outcome, were summarized and analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The age of onset ranged from 2 to 32.8 years old (median age 8.6 years, mean age 9.4 years). The time between first symptoms and diagnosis ranged from a few days to 20 years (median time 2 months, mean time 20.7 months). Neuropsychiatric symptoms were presented as first symptoms in 68.2% of cases, which were observed frequently in schoolchildren or adolescents. Renal involvement and cardiovascular disease were observed in 20% and 8.2% of cases, respectively, which occurred with the highest prevalence in preschool children. Besides the initial symptoms, the disease progressed in most patients and cognitive decline became the most frequent symptom overall. The levels of propionylcarnitine, propionylcarnitine \/ acetylcarnitine ratio, methylmalonic acid, methylcitric acid and homocysteine, were decreased remarkably after treatment (\n                      <jats:italic>P<\/jats:italic>\n                      &lt;0.001). Twenty-four different mutations of\n                      <jats:italic>MMACHC<\/jats:italic>\n                      were identified in 78 patients, two of which were novel. The c.482G&gt;A variant was the most frequent mutated allele in this cohort (25%). Except for 16 patients who recovered completely, the remaining patients were still left with varying degrees of sequelae in a long-term follow-up. The available data from 76 cases were analyzed by univariate analysis and multivariate logistic regression analysis, and the results showed that the time from onset to diagnosis (OR\u2009=\u20091.025,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090. 024) was independent risk factors for poor outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The diagnosis of late-onset cblC defect is often delayed due to poor awareness of its various and nonspecific symptoms, thus having an adverse effect on the prognosis. It should be considered in patients with unexplained neuropsychiatric and other conditions such as renal involvement, cardiovascular diseases or even multiple organ damage. The c.482G&gt;A variant shows the highest frequency in these patients. Prompt treatment appears to be beneficial.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-023-02890-4","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T07:03:02Z","timestamp":1695884582000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Late-onset cblC defect: clinical, biochemical and molecular analysis"],"prefix":"10.1186","volume":"18","author":[{"given":"Si","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiying","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4209-5119","authenticated-orcid":false,"given":"Lianshu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"issue":"1","key":"2890_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/ng1683","volume":"38","author":"JP Lerner-Ellis","year":"2006","unstructured":"Lerner-Ellis JP, Tirone JC, Pawelek PD, Dor\u00e9 C, Atkinson JL, Watkins D, Morel CF, Fujiwara TM, Moras E, Hosack AR, et al. Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type. Nat Genet. 2006;38(1):93\u2013100.","journal-title":"Nat Genet"},{"issue":"1","key":"2890_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10545-010-9161-z","volume":"34","author":"D Martinelli","year":"2011","unstructured":"Martinelli D, Deodato F, Dionisi-Vici C. Cobalamin C defect: natural history, pathophysiology, and treatment. J Inherit Metab Dis. 2011;34(1):127\u201335.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"2890_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13023-019-1063-z","volume":"14","author":"T Alm\u00e1si","year":"2019","unstructured":"Alm\u00e1si T, Guey LT, Lukacs C, Csetneki K, Vok\u00f3 Z, Zelei T. Systematic literature review and meta-analysis on the epidemiology of methylmalonic acidemia (MMA) with a focus on MMA caused by methylmalonyl-CoA mutase (mut) deficiency. Orphanet J Rare Dis. 2019;14(1):84.","journal-title":"Orphanet J Rare Dis"},{"key":"2890_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cca.2019.12.022","volume":"502","author":"C Yang","year":"2020","unstructured":"Yang C, Zhou C, Xu P, Jin X, Liu W, Wang W, Huang C, Jiang M, Chen X. Newborn screening and diagnosis of inborn errors of metabolism: a 5-year study in an eastern chinese population. Clin Chim Acta. 2020;502:133\u20138.","journal-title":"Clin Chim Acta"},{"issue":"8","key":"2890_CR5","first-page":"86","volume":"0","author":"DL Zhao","year":"2016","unstructured":"Zhao DL, Li XL, Ni M, Jia CL, Zhang J. Screening results of neonatal methylmalonic acidemia (MMA) of 349858 cases in Henan province. Chin J Birth Health Heredity. 2016;0(8):86\u2013790.","journal-title":"Chin J Birth Health Heredity"},{"key":"2890_CR6","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3389\/fgene.2018.00726","volume":"9","author":"W Zhou","year":"2018","unstructured":"Zhou W, Li H, Wang C, Wang X, Gu M. Newborn screening for Methylmalonic Acidemia in a Chinese Population: Molecular Genetic confirmation and genotype phenotype correlations. Front Genet. 2018;9:726.","journal-title":"Front Genet"},{"issue":"12 Suppl","key":"2890_CR7","first-page":"107","volume":"37","author":"X Gu","year":"2008","unstructured":"Gu X, Wang Z, Ye J, Han L, Qiu W. Newborn screening in China: phenylketonuria, congenital hypothyroidism and expanded screening. Ann Acad Med Singap. 2008;37(12 Suppl):107\u2013104.","journal-title":"Ann Acad Med Singap"},{"issue":"3","key":"2890_CR8","first-page":"240","volume":"46","author":"F Hong","year":"2017","unstructured":"Hong F, Huang X, Zhang Y, Yang J, Tong F, Mao H, Huang X, Zhou X, Yang R, Zhao Z. [Screening for newborn organic aciduria in Zhejiang province:prevalence, outcome and follow-up]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2017;46(3):240\u20137.","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"issue":"5","key":"2890_CR9","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s10545-014-9687-6","volume":"37","author":"S Fischer","year":"2014","unstructured":"Fischer S, Huemer M, Baumgartner M, Deodato F, Ballhausen D, Boneh A, Burlina AB, Cerone R, Garcia P, G\u00f6k\u00e7ay G, et al. Clinical presentation and outcome in a series of 88 patients with the cblC defect. J Inherit Metab Dis. 2014;37(5):831\u201340.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"2890_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10545-011-9364-y","volume":"35","author":"N Carrillo-Carrasco","year":"2012","unstructured":"Carrillo-Carrasco N, Chandler RJ, Venditti CP. Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management. J Inherit Metab Dis. 2012;35(1):91\u2013102.","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"2890_CR11","first-page":"414","volume":"56","author":"Y Liu","year":"2018","unstructured":"Liu Y, Liu YP, Zhang Y, Song JQ, Zheng H, Dong H, Ma YY, Wu TF, Wang Q, Li XY, et al. [Heterogeneous phenotypes, genotypes, treatment and prevention of 1 003 patients with methylmalonic acidemia in the mainland of China]. Zhonghua Er Ke Za Zhi. 2018;56(6):414\u201320.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"Suppl 3","key":"2890_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10545-010-9217-0","volume":"33","author":"F Wang","year":"2010","unstructured":"Wang F, Han L, Yang Y, Gu X, Ye J, Qiu W, Zhang H, Zhang Y, Gao X, Wang Y. Clinical, biochemical, and molecular analysis of combined methylmalonic acidemia and hyperhomocysteinemia (cblC type) in China. J Inherit Metab Dis. 2010;33(Suppl 3):435\u201342.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"2890_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13023-022-02179-y","volume":"17","author":"S Kalantari","year":"2022","unstructured":"Kalantari S, Brezzi B, Bracciam\u00e0 V, Barreca A, Nozza P, Vaisitti T, Amoroso A, Deaglio S, Manganaro M, Porta F, et al. Adult-onset CblC deficiency: a challenging diagnosis involving different adult clinical specialists. Orphanet J Rare Dis. 2022;17(1):33.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"2890_CR14","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/jimd.12012","volume":"42","author":"M Huemer","year":"2019","unstructured":"Huemer M, Baumgartner MR. The clinical presentation of cobalamin-related disorders: from acquired deficiencies to inborn errors of absorption and intracellular pathways. J Inherit Metab Dis. 2019;42(4):686\u2013705.","journal-title":"J Inherit Metab Dis"},{"key":"2890_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13023-014-0161-1","volume":"9","author":"M Huemer","year":"2014","unstructured":"Huemer M, Scholl-B\u00fcrgi S, Hadaya K, Kern I, Beer R, Seppi K, Fowler B, Baumgartner MR, Karall D. Three new cases of late-onset cblC defect and review of the literature illustrating when to consider inborn errors of metabolism beyond infancy. Orphanet J Rare Dis. 2014;9:161.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2890_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10545-016-9991-4","volume":"40","author":"M Huemer","year":"2017","unstructured":"Huemer M, Diodato D, Schwahn B, Schiff M, Bandeira A, Benoist JF, Burlina A, Cerone R, Couce ML, Garcia-Cazorla A, et al. Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency. J Inherit Metab Dis. 2017;40(1):21\u201348.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"2890_CR17","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/jimd.12370","volume":"44","author":"P Forny","year":"2021","unstructured":"Forny P, H\u00f6rster F, Ballhausen D, Chakrapani A, Chapman KA, Dionisi-Vici C, Dixon M, Gr\u00fcnert SC, Grunewald S, Haliloglu G, et al. Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: first revision. J Inherit Metab Dis. 2021;44(3):566\u201392.","journal-title":"J Inherit Metab Dis"},{"key":"2890_CR18","doi-asserted-by":"publisher","first-page":"702374","DOI":"10.3389\/fgene.2021.702374","volume":"12","author":"EH Liang","year":"2021","unstructured":"Liang EH, Zhang L, Qiu H, Ye W, Xu J, Gong F, Gu Z, Han X. Evaluation of the clinical, biochemical, neurological, and genetic presentations of glutaric aciduria type 1 in patients from China. Front Genet. 2021;12:702374.","journal-title":"Front Genet"},{"issue":"4","key":"2890_CR19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ymgme.2013.05.013","volume":"109","author":"C Dionisi-Vici","year":"2013","unstructured":"Dionisi-Vici C, Martinelli D, Ceravolo F, Boenzi S, Pastore A. Optimizing the dose of hydroxocobalamin in cobalamin C (cblC) defect. Mol Genet Metab. 2013;109(4):329\u201330.","journal-title":"Mol Genet Metab"},{"issue":"7","key":"2890_CR20","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/humu.21001","volume":"30","author":"JP Lerner-Ellis","year":"2009","unstructured":"Lerner-Ellis JP, Anastasio N, Liu J, Coelho D, Suormala T, Stucki M, Loewy AD, Gurd S, Grundberg E, Morel CF, et al. Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype-phenotype correlations. Hum Mutat. 2009;30(7):1072\u201381.","journal-title":"Hum Mutat"},{"issue":"1\u20132","key":"2890_CR21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ymgme.2017.06.011","volume":"122","author":"M Almannai","year":"2017","unstructured":"Almannai M, Marom R, Divin K, Scaglia F, Sutton VR, Craigen WJ, Lee B, Burrage LC, Graham BH. Milder clinical and biochemical phenotypes associated with the c.482G > A (p.Arg161Gln) pathogenic variant in cobalamin C disease: implications for management and screening. Mol Genet Metab. 2017;122(1\u20132):60\u20136.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"2890_CR22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s13023-022-02471-x","volume":"17","author":"Z Chen","year":"2022","unstructured":"Chen Z, Dong H, Liu Y, He R, Song J, Jin Y, Li M, Liu Y, Liu X, Yan H, et al. Late-onset cblC deficiency around puberty: a retrospective study of the clinical characteristics, diagnosis, and treatment. Orphanet J Rare Dis. 2022;17(1):330.","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"2890_CR23","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1007\/s00247-008-0940-8","volume":"38","author":"A Radmanesh","year":"2008","unstructured":"Radmanesh A, Zaman T, Ghanaati H, Molaei S, Robertson RL, Zamani AA. Methylmalonic acidemia: brain imaging findings in 52 children and a review of the literature. Pediatr Radiol. 2008;38(10):1054\u201361.","journal-title":"Pediatr Radiol"},{"issue":"3","key":"2890_CR24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ymgme.2013.07.018","volume":"110","author":"JD Weisfeld-Adams","year":"2013","unstructured":"Weisfeld-Adams JD, Bender HA, Miley-\u00c5kerstedt A, Frempong T, Schrager NL, Patel K, Naidich TP, Stein V, Spat J, Towns S, et al. Neurologic and neurodevelopmental phenotypes in young children with early-treated combined methylmalonic acidemia and homocystinuria, cobalamin C type. Mol Genet Metab. 2013;110(3):241\u20137.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"2890_CR25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/biof.17","volume":"35","author":"J Zhou","year":"2009","unstructured":"Zhou J, Austin RC. Contributions of hyperhomocysteinemia to atherosclerosis: causal relationship and potential mechanisms. BioFactors. 2009;35(2):120\u20139.","journal-title":"BioFactors"},{"issue":"4","key":"2890_CR26","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.neuroscience.2004.01.058","volume":"125","author":"C Roehrs","year":"2004","unstructured":"Roehrs C, Garrido-Sanabria ER, Da Silva AC, Faria LC, Sinhorin VD, Marques RH, Priel MR, Rubin MA, Cavalheiro EA, Mello CF. Succinate increases neuronal post-synaptic excitatory potentials in vitro and induces convulsive behavior through N-methyl-d-aspartate-mediated mechanisms. Neuroscience. 2004;125(4):965\u201371.","journal-title":"Neuroscience"},{"issue":"1","key":"2890_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13023-020-01485-7","volume":"15","author":"R He","year":"2020","unstructured":"He R, Mo R, Shen M, Kang L, Song J, Liu Y, Chen Z, Zhang H, Yao H, Liu Y, et al. Variable phenotypes and outcomes associated with the MMACHC c.609G > A homologous mutation: long term follow-up in a large cohort of cases. Orphanet J Rare Dis. 2020;15(1):200.","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"2890_CR28","doi-asserted-by":"publisher","first-page":"103713","DOI":"10.1016\/j.ejmg.2019.103713","volume":"62","author":"C Wang","year":"2019","unstructured":"Wang C, Li D, Cai F, Zhang X, Xu X, Liu X, Zhang C, Wang D, Liu X, Lin S, et al. Mutation spectrum of MMACHC in chinese pediatric patients with cobalamin C disease: a case series and literature review. Eur J Med Genet. 2019;62(10):103713.","journal-title":"Eur J Med Genet"},{"key":"2890_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13023-014-0130-8","volume":"9","author":"MR Baumgartner","year":"2014","unstructured":"Baumgartner MR, H\u00f6rster F, Dionisi-Vici C, Haliloglu G, Karall D, Chapman KA, Huemer M, Hochuli M, Assoun M, Ballhausen D, et al. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis. 2014;9:130.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2890_CR30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0022-3476(88)80114-8","volume":"112","author":"DW Bartholomew","year":"1988","unstructured":"Bartholomew DW, Batshaw ML, Allen RH, Roe CR, Rosenblatt D, Valle DL, Francomano CA. Therapeutic approaches to cobalamin-C methylmalonic acidemia and homocystinuria. J Pediatr. 1988;112(1):32\u20139.","journal-title":"J Pediatr"},{"issue":"Suppl 2","key":"2890_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/PL00014307","volume":"157","author":"H Ogier de Baulny","year":"1998","unstructured":"Ogier de Baulny H, G\u00e9rard M, Saudubray JM, Zittoun J. Remethylation defects: guidelines for clinical diagnosis and treatment. Eur J Pediatr. 1998;157(Suppl 2):77\u201383.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"2890_CR32","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/ana.78","volume":"49","author":"JM Powers","year":"2001","unstructured":"Powers JM, Rosenblatt DS, Schmidt RE, Cross AH, Black JT, Moser AB, Moser HW, Morgan DJ. Neurological and neuropathologic heterogeneity in two brothers with cobalamin C deficiency. Ann Neurol. 2001;49(3):396\u2013400.","journal-title":"Ann Neurol"},{"issue":"1","key":"2890_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.braindev.2004.04.004","volume":"27","author":"D Hori","year":"2005","unstructured":"Hori D, Hasegawa Y, Kimura M, Yang Y, Verma IC, Yamaguchi S. Clinical onset and prognosis of asian children with organic acidemias, as detected by analysis of urinary organic acids using GC\/MS, instead of mass screening. Brain Dev. 2005;27(1):39\u201345.","journal-title":"Brain Dev"},{"issue":"3","key":"2890_CR34","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10545-015-9907-8","volume":"39","author":"J Heringer","year":"2016","unstructured":"Heringer J, Valayannopoulos V, Lund AM, Wijburg FA, Freisinger P, Bari\u0107 I, Baumgartner MR, Burgard P, Burlina AB, Chapman KA, et al. Impact of age at onset and newborn screening on outcome in organic acidurias. J Inherit Metab Dis. 2016;39(3):341\u201353.","journal-title":"J Inherit Metab Dis"},{"issue":"1\u20132","key":"2890_CR35","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.clinbiochem.2012.09.013","volume":"46","author":"KK Ryckman","year":"2013","unstructured":"Ryckman KK, Berberich SL, Shchelochkov OA, Cook DE, Murray JC. Clinical and environmental influences on metabolic biomarkers collected for newborn screening. Clin Biochem. 2013;46(1\u20132):133\u20138.","journal-title":"Clin Biochem"},{"issue":"5","key":"2890_CR36","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/jimd.12236","volume":"43","author":"G Peng","year":"2020","unstructured":"Peng G, Tang Y, Gandotra N, Enns GM, Cowan TM, Zhao H, Scharfe C. Ethnic variability in newborn metabolic screening markers associated with false-positive outcomes. J Inherit Metab Dis. 2020;43(5):934\u201343.","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"2890_CR37","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s10545-014-9727-2","volume":"37","author":"J Estrella","year":"2014","unstructured":"Estrella J, Wilcken B, Carpenter K, Bhattacharya K, Tchan M, Wiley V. Expanded newborn screening in New South Wales: missed cases. J Inherit Metab Dis. 2014;37(6):881\u20137.","journal-title":"J Inherit Metab Dis"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02890-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02890-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02890-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T11:41:31Z","timestamp":1700307691000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02890-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2890"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02890-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2832403\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]},"assertion":[{"value":"19 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants, and our study was approved by the Ethics Committee of Xinhua Hospital (Approval No. XHEC-D-2023-058).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Participants provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None declared.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"306"}}